Free Trial

Acutus Medical Q2 2023 Earnings Report

Acutus Medical logo
$0.05 +0.00 (+2.46%)
As of 03:07 PM Eastern

Acutus Medical EPS Results

Actual EPS
-$0.63
Consensus EPS
-$0.61
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

Acutus Medical Revenue Results

Actual Revenue
$5.29 million
Expected Revenue
$4.60 million
Beat/Miss
Beat by +$690.00 thousand
YoY Revenue Growth
N/A

Acutus Medical Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Despite the Tesla Crash, These Traders Are 9 for 9 (Ad)

Most Tesla shareholders are disappointed in the stock's performance in 2024, with a 30% decline year to date. But not this guy… One trader has found a way to turn Tesla’s downfall into a flurry of opportunity. In fact, he hasn’t lost a single trade on Tesla this year! See for yourself (Notice how short of a time period he holds onto the stock):

*Get Access To the Free Training Here!*

Acutus Medical Earnings Headlines

Acutus Medical Announces Operational Downsizing
Acutus Medical Reports Q3 2024 Financial Results
Combine the QQQ, IWM and SPY in one trade
If you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses…
See More Acutus Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Acutus Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Acutus Medical and other key companies, straight to your email.

About Acutus Medical

Acutus Medical (NASDAQ:AFIB) designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

View Acutus Medical Profile

More Earnings Resources from MarketBeat